Effect of Sequential Intravenous and Oral Tranexamic Acid on Hemoglobin Drop After Total Knee Arthroplasty: A Randomized Controlled Trial.
This report has been verified
by one or more authors of the
original publication.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2022;10(6):8 J Bone Joint Surg Am. 2022 Jan 19;104(2): 154-159.What this means for my practice?
In patients undergoing primary TKA, the sequential administration of oral TXA following IV TXA administration does not reduce blood loss.
Study Summary
One hundred and forty one patients undergoing primary TKA were randomized to receive perioperative intravenous tranexamic acid (IV-TXA) alone (n=48), IV TXA followed by oral TXA for 2 days (2D, n=46) or oral TXA for 5 days (5D, n=47). The primary outcome of interest were maximal drops in hemoglobin, estimated blood loss, transfusion rates and complications. There was no significant differences in hemoglobin drops, estimated blood loss, transfusion rates or postoperative complications.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
